North America Biomaterials Market

North America Biomaterials Market Size (2023 to 2028)

The North America biomaterials market size is predicted to be USD 43975 Million by 2023 and USD 85904 Million in 2028, growing at a CAGR of 14.33% during the forecast period, acting as a top-performing region in the global biomaterials market. In a short period, many patients worldwide have the quality of their lives improved with the aid of some implanted device. The materials from which these devices are built include metals, ceramics, polymers, and an array of composites. As we reach the end of the 20th century, the success of using these materials is increasing, both because of improved surgical skills, an improved understanding of how the body interacts with such devices.

The rise in the research and development institutes to develop innovative procedures in the medical sector is lavishing the market's demand extensively. In addition, biomaterials play a significant role in repairing or replacing a tissue function of the body, which is also an attribute fuelling the market's growth. Besides, the growing prevalence of novel biomaterials and their developments makes the shares of the market expansion in North America. Furthermore, increasing beauty consciousness and increasing preference for plastic surgery are leveraging the growth of the market.

However, the lack of knowledge over the best usage of the materials is slowly degrading the market's growth. The equipment in the laboratories requires massive amounts for installation and maintenance, which has remained a challenging attribute for the North America Biomaterials market developers. Stringent rules and regulations by the government in concern towards patient health conditions are limiting the market's growth.

Growing demand for effective treatment or diagnostic procedures in the medical sector is a significant factor anticipated to surge growth opportunities for the market. In addition, increasing incidences of chronic diseases and other infectious diseases are creating chances for the market. Furthermore, a rise in the funds from private and public organizations significantly influences the demand of the market. Also, increasing focus on introducing innovative products with the latest technology and ensuring better treatment procedures is ascribed to bolster the market's need.

This research report on the North American Biomaterials market has been segmented and sub-segmented the North America biomaterials market into the following categories:

By Material Type:

• Ceramic
• Metallic
• Polymer
• Natural

By Application:

• Orthopedic
• Dental
• Cardiovascular
• Plastic surgery
• Wound healing
• Ophthalmology
• Tissue engineering
• Neurological
• Others

By Region:

• The United States
• Canada
• Rest of North America

Regionally, the U.S. biomaterials market holds the highest shares of the market from the past decade and continues the same growth in the forecast period. A rise in capital income is one of the factors propelling the demand of the market. The increasing number of patients with cardiovascular problems is also likely to outshine the growth of the biomaterials market in the U.S.

The Canadian biomaterials market is positioned second in the leading dominant shares with the rise in the scale of pharmaceutical companies. Growing investments by the government in the construction of hospitals are leveraging the growth of the market. Also, increasing demand to level up the quality of medical products is accelerating the market's need.

KEY MARKET PLAYERS:

A few of the promising companies operating in the North American biomaterials market are DSM, Zimmer Biomet Holdings, Inc., Evonik Industries AG, Wright Medical Technology, Inc., Corbion N.V., Berkeley Advanced Biomaterials, Bayer AG, Carpenter Technology Corporation, Covalon Technologies Ltd., BASF SE, Invibio Ltd., Inc., CAM Bioceramics BV and Collagen Matrix, Inc.